Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost

Author： Feldman Steven R Garton Rachel Averett William Balkrishnan Rajesh Vallee Jeffrey

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.9, 2003-09, pp. : 1525-1533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of moderate-to-severe psoriasis treatment

By Miller Drew W Feldman Steven R

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 157-167

Informa Healthcare

Access to resources Recommend Favorite

A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency

By Staidle Jonathan P Dabade Tushar S Feldman Steven R

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2041-2054

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations

By Hashim Hashim Paul Abrams

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1643-1656

Adis International

Access to resources Recommend Favorite

Efficacy and safety of oral retinoids in psoriasis

By Van Zander JoEllen Orlow Seth J

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 129-138

Informa Healthcare

Access to resources Recommend Favorite

Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 964-978

Bentham Science Publishers

Access to resources Recommend Favorite